VivoSeq
Other

Chronic Post-Surgical Pain

2

Pipeline Programs

5

Active Trials

0

Companies Involved

Chronic Post-surgical Pain is an early-stage landscape with 2 programs across 0 companies. 2 therapies are approved.

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

11/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

7

clinical trials

Enrolling by invitation2 · 29%
Completed2 · 29%
Recruiting1 · 14%
Active, not recruiting1 · 14%
Not yet recruiting1 · 14%

Trial Activity

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)